Verition Fund Management’s Medline MDLN Stock Holding History
Bought
Maintained
Sold
Other funds holding MDLN
Verition Fund Management's MDLN Position: Q3 2026 in Review
Verition Fund Management sold out of Medline (MDLN) in Q3 2026, closing a stake of 915,000 shares — an estimated $36.1M sold.
Verition Fund Management first reported a position in MDLN in Q4 2025 and held it in 3 quarters. The position peaked at $38.1M in Q1 2026. 415 funds tracked by Wall St. Rank hold MDLN as of Q3 2026.
- Verition Fund Management reported no remaining Medline position as of Q3 2026 after selling out during the quarter.
- Verition Fund Management sold 915,000 Medline shares in Q3 2026, an estimated $36.1M.
- Verition Fund Management first reported a position in Medline in Q4 2025 and held it in 3 quarters.
- Verition Fund Management's Medline position peaked at $38.1M in Q1 2026.
- 415 funds tracked by Wall St. Rank held Medline as of Q3 2026.
Based on Verition Fund Management's 13F filing for Q3 2026, filed 13 Nov 2026.